Aws Aljanabi, MD
Nephrology · Toledo, OHNPI 1467825711
Payments from drug & device makers
What this record shows
Medtronic accounts for 65.1% of it on its own, with 6 other manufacturers making up the rest. 2024 is the largest year on record at $1,287, 8.4 times the $153 reported in 2019.
Across 14 payments — averaging $130.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Otsuka America Pharmaceutical, Inc.$153
- Bard Peripheral Vascular, Inc.$141
- Veloxis Pharmaceuticals, Inc.$123
- Fresenius USA Marketing, Inc.$121
- Baxter Healthcare$81
- plus $17 from 1 others
What the payments were for
- Travel & lodging$1,07459%
- Food & beverage$75141%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 8 | $1,189 |
| Otsuka America Pharmaceutical, Inc. | 1 | $153 |
| Bard Peripheral Vascular, Inc. | 1 | $141 |
| Veloxis Pharmaceuticals, Inc. | 1 | $123 |
| Fresenius USA Marketing, Inc. | 1 | $121 |
| Baxter Healthcare | 1 | $81 |
| Argon Medical Devices, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ELLIPSYS VASCULAR ACCESS SYSTEM$1,062
- JYNARQUE$153
- VENOVO$141
- Envarsus$123
- Velphoro$121
How this compares
$1,825 in reported general payments places this provider in the 60th percentile of 450 nephrology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 15 | $16,906 |
| Spironolactone | 14 | $308 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Toledo
- Ramy FayadToledo$8K
- Brad RovinColumbus$379K
- Nissreen ElfadawyChardon$327K
- Andrew LazarBeachwood$315K
- Amit GovilCincinnati$298K
- Georges NakhoulCleveland$255K
- Sankar NavaneethanCleveland$253K
- Ibrahim AhmadKettering$232K
- Prabir Roy ChaudhuryCincinnati$205K
- Rupesh RainaAkron$163K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.